Lovastatin for Treatment of Brain Arteriovenous Malformations

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1244 participants.

Also called NCT04297033

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 1,244 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04297033
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04297033. Randomized; double masking; primary purpose treatment. Start 2021-01-01 (anticipated); primary completion 2024-06-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Lovastatin for Treatment of Brain Arteriovenous Malformations
Condition
Cerebral Arteriovenous Malformation
Intervention (Drug)
Lovastatin
Intervention (Drug)
Placebo
Lead sponsor
Beijing Tiantan Hospital (class: other)

Record details

Record id
cardio:ct-nct04297033
Content hash
6e306faed7a80de079709779386f60efb8e6005457002e5d6319d8a1af0cc186